Lung Adenocarcinoma With Primary LIMD1-BRAF Fusion Treated With MEK Inhibitor: A Case Report
Chengyou Wang, Jiun‐Yi Hsia, Che-Hsing Li, Chao‐Chi Ho, Wan‐Ru Chao, Ming‐Fang Wu
Topics & Concepts
TrametinibMedicineCancer researchMEK inhibitorKinaseProtein kinase ALung cancerAdenocarcinomaMAPK/ERK pathwayDabrafenibCancerOncologyInternal medicineBiologyMelanomaVemurafenibCell biologyMetastatic melanomaMelanoma and MAPK PathwaysCancer Mechanisms and TherapyLung Cancer Treatments and Mutations